awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39985219-4E700D0C-BF03-48CC-AF33-7B9E9FC7DACF
Q39985219-4E700D0C-BF03-48CC-AF33-7B9E9FC7DACF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39985219-4E700D0C-BF03-48CC-AF33-7B9E9FC7DACF
The safety of vedolizumab for ulcerative colitis and Crohn's disease.
P2860
Q39985219-4E700D0C-BF03-48CC-AF33-7B9E9FC7DACF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39985219-4E700D0C-BF03-48CC-AF33-7B9E9FC7DACF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1975dde1daaa04292ea88de5110875f1e8b76642
P2860
Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients.